/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
ResMed Inc. (RMD), based in San Diego, California, is a leading provider of cloud-connected devices and digital health solutions, impacting millions of patients worldwide. With a market capitalization of $35 billion, the company is dedicated to enhancing the quality of life for individuals suffering from sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory ailments through cutting-edge, technology-driven innovations.
Companies valued at $10 billion or more are classified as "large-cap" stocks and ResMed rightly fits into this category, underscoring its substantial global presence and consistent growth in the healthcare sector. The company leverages its strong position in the healthcare industry through its innovative cloud-connected devices and digital health solutions. Its robust global presence, significant expertise in respiratory care, and continuous investment in research and development aid in its industry leadership.